print

Country Report

Japan Flag Dermatologicals in Japan

| Pages: 32

Price: US$990

About this Report

Executive Summary

TRENDS

  • Retail value sales of dermatologicals in Japan increased by 2% in current value terms in 2014. Hair loss treatments continued to hold the largest value share of 26%. The category is led by RiUP by Taisho Pharmaceutical, supported by the research findings by the Japanese Dermatological Association that certified the effectiveness of the key active ingredient in RiUP. Hair loss treatments was largely affected by the tax hike in April 2014 because of its relatively high retail price and long shelf life. Consumers had rushed to purchase hair loss treatments before the retail price increased. While men’s hair loss treatments accounted for the majority of total sales, women’s hair loss treatments expanded its value share in 2014 with several new product launches. In addition to women in middle-age and above, an increasing number of young women in their 30s are using hair loss treatment products for prevention purposes.

COMPETITIVE LANDSCAPE

  • Taisho Pharmaceutical Co Ltd remained the top player in dermatologicals. Its brand RiUP continued to dominate hair loss treatments, with retail value share of 48% in 2014. The performance of RiUP in 2014 was largely affected by the tax hike in April 2014. Due to the high unit price of RiUP, many consumers purchased the brand by the end of March 2014. After the tax hike, the value sales of the brand dropped. Kao Corp’s Success ranked second. Compared to RiUP, Success is popular among younger consumers because of its affordable pricing. Other players actively promoted women’s hair loss treatments in 2014. Bathclin Corp launched Mouga L Molty Este Care Line from its hair loss treatments brand Mouga in August 2014. The newly launched cleansing oil and hair oil are intended for female consumers to enjoy the same positive effects on their hair as at beauty salons. RiUP also offers a hair loss treatment for women, RiUP Regenne, although its retail value sales remained low in 2014.

PROSPECTS

  • Dermatologicals is expected to register a marginal value CAGR at constant 2014 prices over the forecast period. Cold sore treatments is expected to continue to record the fastest growth but account for only 4% share of total retail value sales of dermatologicals in 2019. Retail value sales of hair loss treatments are expected to grow steadily, driven by growing demand among female consumers. More products marketed for female hair loss treatments are expected to be introduced over the forecast period. Given the low risk of side-effects in dermatologicals, private label is expected to increase its presence over the forecast period.

Samples (FAQs about samples):

doc_pdf.png Sample Medicated Skin Care Market Research Report

doc_excel_table.png Sample Medicated Skin Care Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Japan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Japan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Japan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Japan?
  • What are the major brands in Japan?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Dermatologicals in Japan - Category Analysis

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

CATEGORY DATA

  • Table 1 Sales of Dermatologicals by Category: Value 2009-2014
  • Table 2 Sales of Dermatologicals by Category: % Value Growth 2009-2014
  • Table 3 NBO Company Shares of Dermatologicals: % Value 2010-2014
  • Table 4 LBN Brand Shares of Dermatologicals: % Value 2011-2014
  • Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2011-2014
  • Table 6 Forecast Sales of Dermatologicals by Category: Value 2014-2019
  • Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2014-2019

Dermatologicals in Japan - Company Profiles

Daiichi Sankyo Healthcare Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
  • Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2014

Taisho Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 4 Taisho Pharmaceutical Co Ltd: Key Facts
  • Summary 5 Taisho Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Taisho Pharmaceutical Co Ltd: Competitive Position 2014

Takeda Pharmaceutical Co Ltd in Consumer Health (Japan)

STRATEGIC DIRECTION

KEY FACTS

  • Summary 7 Takeda Pharmaceutical Co Ltd: Key Facts
  • Summary 8 Takeda Pharmaceutical Co Ltd: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Takeda Pharmaceutical Co Ltd: Competitive Position 2014

Consumer Health in Japan - Industry Context

EXECUTIVE SUMMARY

Modest positive growth in 2014

Japanese government continues to take initiative toward self-medication

Competition intensifies with new product launches

OTC internet retailing officially legalised

Consumer health expected to register flat growth

KEY TRENDS AND DEVELOPMENTS

OTC internet retailing officially legalised

Drugstores and chemists being transformed to the self-medication platform

New product launches with specific positioning revitalise the market

MARKET INDICATORS

  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
  • Table 9 Life Expectancy at Birth 2009-2014

MARKET DATA

  • Table 10 Sales of Consumer Health by Category: Value 2009-2014
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2009-2014
  • Table 12 NBO Company Shares of Consumer Health: % Value 2010-2014
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2011-2014
  • Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
  • Table 15 Distribution of Consumer Health by Format: % Value 2009-2014
  • Table 16 Distribution of Consumer Health by Format and Category: % Value 2014
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2014-2019
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

  • Summary 10 OTC: Switches 2012-2014

DEFINITIONS

SOURCES

  • Summary 11 Research Sources

Segmentation

This market research report includes the following:

  • Dermatologicals
    • Medicated Shampoos
    • Topical Antifungals
    • Vaginal Antifungals
    • Hair Loss Treatments
    • Nappy (Diaper) Rash Treatments
    • Antiparasitics/Lice (Head and Body) Treatments
    • Antipruritics
    • Cold Sore Treatments
    • Haemorrhoid Treatments
    • Paediatric Dermatologicals
    • Topical Allergy Remedies/Antihistamines
    • Topical Germicidals/Antiseptics

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market Sizes
  • Company Shares
  • Brand Shares
  • Distribution
  • Pricing
  • Herbal/Traditional vs Standard

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

print

Recently Viewed Items more ›

    Want to find out more about this report?

    If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!
    Our site uses cookies to improve functionality. Continue if you are happy with this or learn how to manage cookies by clicking here